WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'8001 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 11'7391 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 20'798  20'714  20'624  20'527  20'425  18'782  17'330  15'036 
Births 318  323  328  334  341  348  357  406 
Surviving infants 316  321  326  332  338  343  349  393 
Pop. less than 5 years 1'602  1'643  1'675  1'710  1'744  1'642  1'780  1'911 
Pop. less than 15 years 5'051  5'090  5'113  5'129  5'138  5'025  5'563  5'397 
Female 15-49 years 5'334  5'332  5'337  5'340  5'343  5'177  4'537  3'751 

Number of reported cases

(Click for retrospective incidence data for Sri Lanka)
Diphtheria
ChartChart
  37 
Japanese encephalitis
ChartChart
  18  17  21  70  60 
Measles
ChartChart ChartChart
  112  1'568  1'686  2'107  51  16'527  4'004  5'032 
Mumps
ChartChart
  311  338  383  1'274  3'558  901 
Pertussis
ChartChart
  54  107  38  67  61  194  271  542 
Polio*
ChartChart
  264 
Rubella
ChartChart
  10  24  54  29 
Rubella (CRS)
ChartChart
  12  26 
Tetanus (neonatal)
ChartChart
  339 
Tetanus (total)**
ChartChart
  15  19  97  183  1'243 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sri Lanka)
Vaccine year result method % card seen                                                
BCG 2006  100  DHS   93  99  99  99  99  99  99*  84  61 
DTP1 2006  100  DHS   93  99  99  99  99  99  96 
DTP3 2006  99  DHS   93  99  99  99  99  99  99*  86  46 
DTP4          99  99  99 
IPV1          99  99 
HepB_BD         
HepB3          99  99  99  99  99 
Hib3          99  99  99  99  99 
JapEnc          99  99  99  99  99 
MCV1          99  99  99  99  99  99  80 
MCV2          99  99  99  99  99 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2006  99  DHS   93  99  99  99  99  99  99*  86  46 
Rota1         
RotaC         
RCV1          99  99  99  99 
TT2plus 1992  65  DHS     99  99  99  99  99  99*  68  50 
PAB          99* 
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sri Lanka)
BCG
  99  99  99  99  99  98  84  61 
DTP1
  99  99  99  99  99  99  95  71 
DTP3
  99  99  99  99  99  99  86  46 
HepB3
  99  99  99  99  99 
HepB_BD
 
Hib3
  99  99  99  99  99 
IPV1
  99  47 
MCV1
  99  99  99  99  99  99  80 
MCV2
  99  99  99  99  99 
PCV3
 
Pol3
  99  99  99  99  99  99  86  46 
RCV1
  99  99  99  99  99  99 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 26  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
IPV 2, 4 months; Yes
JE_LiveAtd 1 year; Yes
MMR 9 months; 3 years; Yes
OPV 2, 4, 6, 18 months; 5 years; Yes
Td 12 years; Yes
TT During pregnancies; Yes
Typhoid Yes high risk categories, food handlers, based on transmission pattern and data, districts wre selected to provide vaccination
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2021  2012- 2016  2011-2016  2011-2016    2012 - 2017  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 26  26  26  26  26  26  26 

System performance

Total Nº districts in country number 26  26  26  26  26  26  26 
Nº districts with DTP3 coverage >=80% number 26  26  26  26  25  26  26 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  96  100  100 
Nº districts with measles (MCV1) coverage >=95% number 23  26  26  15  17  16  14 
% of districts with MCV1 coverage >=95% From 0 to 100% 88  100  100  58  65  62  54 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%   74  93  100    97  77 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.